Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term
Portfolio Pulse from
Becton Dickinson (BDX), a medical technology company, is highlighted as a potential growth stock with a Zacks Rank of #3 (Hold) and a VGM Score of B. The company demonstrates promising growth characteristics, including a projected year-over-year earnings growth of 9.8% and positive earnings estimate revisions from five analysts.
March 21, 2025 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medical technology company shows promising growth indicators with positive analyst revisions and solid financial outlook.
Positive earnings estimate revisions, strong Growth Style Score, and consistent performance suggest potential short-term stock price appreciation.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100